Redifferentiation Therapy for Iodine Refractory Differentiated Thyroid Cancers: Current Status

被引：0
|
作者：
Wadsley, Jonathan [1 ]
机构：
[1] Weston Pk Canc Ctr, Whitham Rd, Sheffield S10 2SJ, England
来源：
THYROID | 2023年 / 33卷 / 06期
关键词：
EFFICACY;
D O I：
10.1089/thy.2023.0057
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：662 / 663
页数：2
相关论文
共 50 条
  • [21] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
    Lu Zhang
    Zhi Li
    Meng Zhang
    Huangren Zou
    Yuke Bai
    Yanlin Liu
    Juan Lv
    Ling Lv
    Pengjie Liu
    Zhiyong Deng
    Chao Liu
    Medical Oncology, 40
  • [22] MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer
    Leboulleux, Sophie
    Benisvy, Daniele
    Taieb, David
    Attard, Marie
    Bournaud, Claire
    Terroir-Cassou-Mounat, Marie
    Lacroix, Ludovic
    Anizan, Nadege
    Schiazza, Aurelie
    Garcia, Marie Eve
    Al Ghuzlan, Abir
    Lamartina, Livia
    Schlumberger, Martin
    Godbert, Yann
    Borget, Isabelle
    THYROID, 2023, 33 (09) : 1124 - 1129
  • [23] Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer
    Shobab, Leila
    Wartofsky, Leonard
    THYROID, 2023, 33 (02) : 138 - 142
  • [24] Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine
    Bulotta, Stefania
    Celano, Marilena
    Costante, Giuseppe
    Russo, Diego
    ENDOCRINE, 2016, 52 (02) : 214 - 221
  • [25] Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers
    French, Jena D.
    Haugen, Bryan R.
    Worden, Francis P.
    Bowles, Daniel W.
    Gianoukakis, Andrew G.
    Konda, Bhavana
    Dadu, Ramona
    Sherman, Eric J.
    McCue, Shaylene
    Foster, Nathan R.
    Nikiforov, Yuri E.
    Farias, Ticiana D. J.
    Norman, Paul J.
    Wirth, Lori J.
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3757 - 3767
  • [26] Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine
    Stefania Bulotta
    Marilena Celano
    Giuseppe Costante
    Diego Russo
    Endocrine, 2016, 52 : 214 - 221
  • [27] Current status of the prediction for radio-iodine refractory thyroid cancer: a narrative review
    Wang, Yuhua
    Lu, Xiurong
    Liu, Haiyan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] Redifferentiation therapy for thyroid cancer
    Park, JW
    Clark, OH
    SURGICAL CLINICS OF NORTH AMERICA, 2004, 84 (03) : 921 - +
  • [29] Radioactive iodine therapy in poorly differentiated thyroid cancer
    Tuttle, R. Michael
    Grewal, Ravinder K.
    Larson, Steve M.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 665 - 668
  • [30] Radioactive iodine therapy in poorly differentiated thyroid cancer
    R Michael Tuttle
    Ravinder K Grewal
    Steve M Larson
    Nature Clinical Practice Oncology, 2007, 4 : 665 - 668
12345